- Home
- CISO vs GDTC Comparison
CISO vs GDTC Comparison
Compare CISO & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CISO
- GDTC
- Stock Information
- Founded
- CISO 2015
- GDTC 2018
- Country
- CISO United States
- GDTC Singapore
- Employees
- CISO N/A
- GDTC N/A
- Industry
- CISO Computer Software: Prepackaged Software
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- CISO Technology
- GDTC Health Care
- Exchange
- CISO Nasdaq
- GDTC Nasdaq
- Market Cap
- CISO 31.4M
- GDTC 21.5M
- IPO Year
- CISO N/A
- GDTC 2023
- Fundamental
- Price
- CISO $1.25
- GDTC $2.21
- Analyst Decision
- CISO
- GDTC Buy
- Analyst Count
- CISO 0
- GDTC 1
- Target Price
- CISO N/A
- GDTC $5.00
- AVG Volume (30 Days)
- CISO 610.4K
- GDTC 13.1K
- Earning Date
- CISO 08-14-2025
- GDTC 01-01-0001
- Dividend Yield
- CISO N/A
- GDTC N/A
- EPS Growth
- CISO N/A
- GDTC N/A
- EPS
- CISO N/A
- GDTC N/A
- Revenue
- CISO $28,792,765.00
- GDTC $368,838.00
- Revenue This Year
- CISO N/A
- GDTC $5.37
- Revenue Next Year
- CISO N/A
- GDTC N/A
- P/E Ratio
- CISO N/A
- GDTC N/A
- Revenue Growth
- CISO N/A
- GDTC N/A
- 52 Week Low
- CISO $0.30
- GDTC $1.20
- 52 Week High
- CISO $3.84
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- CISO 71.25
- GDTC 65.15
- Support Level
- CISO $0.86
- GDTC $1.82
- Resistance Level
- CISO $1.32
- GDTC $2.27
- Average True Range (ATR)
- CISO 0.08
- GDTC 0.09
- MACD
- CISO 0.04
- GDTC 0.04
- Stochastic Oscillator
- CISO 84.10
- GDTC 85.73
About CISO CISO Global Inc.
CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.